Dr. Kaseko chairs the Hybridoma Technology and Antibody Gene Manipulation session at the BIT Life Sciences’ 2nd Annual International Congress of Antibodies
In recognition of the significant advances made in hybridoma technology at SSRI, and its relevance to antibody gene manipulation, Dr. Galina Kaseko was invited to chair the Hybridoma Technology and Antibody Gene Manipulation session at the BIT Life Sciences’ 2nd Annual International Congress of Antibodies in Beijing, China, on 24 March 2010. In addition to chairing the session, Dr. Kaseko took the opportunity to speak about some of the latest research findings at the Institute, concerning the improvement of antibody yields and [...]